IL-4/IL-13 antagonists (Salmedix/University of Caifornia San Diego)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIL-4/IL-13 antagonists (Salmedix/University of Caifornia San Diego)
Drug Alias NameIBT (Salmedix/University of California San Diego)tumor-selective apoptosis inducers (UCSD/Salmedix)IBT analogs (Salmedix/University of California San Diego)IBT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin 13 receptor inhibitorsInterleukin-4 receptors inhibitors
TargetsInterleukin 13 receptorInterleukin-4 receptors
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San Diego
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSalmedix IncUniversity Of California San Diego
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A